NorthCoast Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$642K Buy
2,653
+79
+3% +$19.9K 0.02% 321
2021
Q2
$610K Buy
+2,574
New +$586K 0.02% 318
2021
Q1
Sell
-8,014
Closed -$1.4M 418
2020
Q4
$1.4M Buy
8,014
+375
+5% +$64.8K 0.06% 172
2020
Q3
$1.24M Sell
7,639
-3,406
-31% -$540K 0.06% 170
2020
Q2
$1.58M Buy
11,045
+4,120
+59% +$570K 0.09% 133
2020
Q1
$752K Buy
6,925
+184
+3% +$26.5K 0.05% 175
2019
Q4
$980K Buy
+6,741
New +$973K 0.06% 153
2018
Q4
Sell
-8,685
Closed -$1.3M 247
2018
Q3
$1.3M Buy
+8,685
New +$1.32M 0.08% 144

Other funds holding LH

NorthCoast Asset Management's LH Position: Q3 2021 in Review

NorthCoast Asset Management increased its Labcorp (LH) stake by 3.1% in Q3 2021, buying an estimated $19.9K and bringing the position to 2,653 shares worth $642K. The position accounts for 0.02% of the portfolio, ranked #321.

NorthCoast Asset Management first reported a position in LH in Q3 2018 and has held it in 8 quarters since. The position peaked at $1.58M in Q2 2020. 993 funds tracked by Wall St. Rank hold LH as of Q3 2021.

  • NorthCoast Asset Management held 2,653 shares of Labcorp worth $642K as of Q3 2021.
  • NorthCoast Asset Management bought 79 Labcorp shares in Q3 2021, an estimated $19.9K.
  • Labcorp made up 0.02% of NorthCoast Asset Management's portfolio in Q3 2021, its #321 holding.
  • NorthCoast Asset Management first reported a position in Labcorp in Q3 2018 and has held it in 8 quarters since.
  • NorthCoast Asset Management's Labcorp position peaked at $1.58M in Q2 2020.
  • 993 funds tracked by Wall St. Rank held Labcorp as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.